1 November 2024 false No description of principal activity Taxfiler 2024.6 12578662 business:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 12578662 2024-10-31 12578662 business:EntityHasNeverTraded 2024-11-01 2025-10-31 12578662 2024-11-01 2025-10-31 12578662 business:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 12578662 business:FilletedAccounts 2024-11-01 2025-10-31 12578662 2025-10-31 12578662 2024-10-31 12578662 core:AfterOneYear 2025-10-31 12578662 core:AfterOneYear 2024-10-31 12578662 core:ShareCapital core:PreviouslyStatedAmount 2025-10-31 12578662 core:ShareCapital core:PreviouslyStatedAmount 2024-10-31 12578662 core:SharePremium core:PreviouslyStatedAmount 2025-10-31 12578662 core:SharePremium core:PreviouslyStatedAmount 2024-10-31 12578662 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-10-31 12578662 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-10-31 12578662 core:PreviouslyStatedAmount 2025-10-31 12578662 core:PreviouslyStatedAmount 2024-10-31 12578662 business:SmallEntities 2024-11-01 2025-10-31 12578662 business:Director1 2024-11-01 2025-10-31 12578662 countries:EnglandWales 2024-11-01 2025-10-31 12578662 business:RegisteredOffice 2024-11-01 2025-10-31 12578662 business:OrdinaryShareClass1 2024-11-01 2025-10-31 12578662 business:OrdinaryShareClass1 2023-11-01 2024-10-31 12578662 2023-11-01 2024-10-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 12578662 (England and Wales)
Malpapharm Holdings Ltd Unaudited accounts for the year ended 31 October 2025
Malpapharm Holdings Ltd Unaudited accounts Contents
Page
Statement of financial position
3
Notes to the accounts
4
- 2 -
Malpapharm Holdings Ltd Statement of financial position as at 31 October 2025
2025
2024
Notes
£
£
Called up share capital not paid
10
10
Fixed assets
Investments
4
724,958
724,958
Net current assets
-
-
Total assets less current liabilities
724,968
724,968
Creditors: amounts falling due after more than one year
5
(305,508)
(305,508)
Net assets
419,460
419,460
Capital and reserves
Called up share capital
6
10
10
Share premium
400,000
400,000
Profit and loss account
19,450
19,450
Shareholders' funds
419,460
419,460
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 15 July 2026 and were signed on its behalf by
Mr Malcolm Brown Director Company Registration No. 12578662
- 3 -
Malpapharm Holdings Ltd Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
Malpapharm Holdings Ltd is a private company, limited by shares, registered in England and Wales, registration number 12578662. The registered office is 117 Atwood Road, Manchester, M20 6JW, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention.
Presentation currency
The accounts are presented in £ sterling.
Investments
Investments in shares are included at cost.
4
Investments
Subsidiary undertakings
£
Valuation at 1 November 2024
724,958
Valuation at 31 October 2025
724,958
5
Creditors: amounts falling due after more than one year
2025
2024
£
£
Amounts owed to group undertakings and other participating interests
273,572
305,508
Loans from directors
31,936
-
305,508
305,508
6
Share capital
2025
2024
£
£
Allotted, called up and fully paid:
1,000 Ordinary shares of £0.01 each
10
10
7
Transactions with related parties
Malpapharm Holdings Limited holds a 90% shareholding in Malpapharm Limited. At 31 October 2025, Malpapharm Holdings Limited owed Malpapharm Limited £273,572 (2024: £305,508). No interest is charged on the loan.
- 4 -
Malpapharm Holdings Ltd Notes to the Accounts for the year ended 31 October 2025
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -